See more : Yieh Phui Enterprise Co., Ltd. (2023.TW) Income Statement Analysis – Financial Results
Complete financial analysis of MusclePharm Corporation (MSLP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MusclePharm Corporation, a leading company in the Packaged Foods industry within the Consumer Defensive sector.
You may be interested
- China New Higher Education Group Limited (2001.HK) Income Statement Analysis – Financial Results
- Swire Pacific Limited (SWRBF) Income Statement Analysis – Financial Results
- Sharda Ispat Limited (SHRDAIS.BO) Income Statement Analysis – Financial Results
- Calitech Co., Ltd. (6532.TWO) Income Statement Analysis – Financial Results
- Surrey Bancorp (SRYB) Income Statement Analysis – Financial Results
MusclePharm Corporation (MSLP)
About MusclePharm Corporation
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada. On December 15, 2022, MusclePharm Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Nevada.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 50.04M | 64.44M | 79.67M | 88.11M | 102.16M | 132.50M | 166.86M | 177.39M | 110.88M | 67.06M | 20.84M | 4.05M | 1.02M | 0.00 | 7.98K |
| Cost of Revenue | 44.67M | 44.83M | 70.98M | 69.72M | 71.71M | 88.03M | 109.93M | 121.38M | 77.69M | 52.73M | 14.47M | 2.80M | 922.97K | 0.00 | 0.00 |
| Gross Profit | 5.37M | 19.61M | 8.69M | 18.39M | 30.45M | 44.47M | 56.93M | 56.01M | 33.19M | 14.33M | 6.37M | 1.24M | 94.95K | 0.00 | 7.98K |
| Gross Profit Ratio | 10.73% | 30.43% | 10.91% | 20.88% | 29.80% | 33.56% | 34.12% | 31.57% | 29.94% | 21.37% | 30.56% | 30.71% | 9.33% | 0.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 893.00K | 751.00K | 642.00K | 1.87M | 4.25M | 4.00M | 1.12M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 16.33M | 20.42M | 22.54M | 25.58M | 39.71M | 57.35M | 43.34M | 30.84M | 14.63M | 22.59M | 19.49M | 822.32K | 20.26K | 1.00M |
| Selling & Marketing | 4.39M | 507.00K | 2.49M | 2.94M | 9.35M | 10.65M | 26.99M | 28.05M | 15.53M | 8.43M | 0.00 | 0.00 | 1.07M | 4.17K | 1.62K |
| SG&A | 4.39M | 16.84M | 22.90M | 25.48M | 34.94M | 50.36M | 84.33M | 71.39M | 46.37M | 23.06M | 22.59M | 19.49M | 1.89M | 24.43K | 1.00M |
| Other Expenses | 9.89M | 9.87M | 14.00M | 0.00 | 1.88M | 35.32M | 83.26M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.40K | -48.85K | 0.00 |
| Operating Expenses | 14.28M | 16.84M | 23.80M | 26.23M | 37.45M | 52.23M | 88.59M | 75.39M | 47.49M | 23.06M | 22.59M | 19.49M | 1.91M | -24.43K | 1.00M |
| Cost & Expenses | 58.96M | 61.67M | 94.77M | 95.95M | 109.16M | 140.26M | 198.51M | 196.77M | 125.17M | 75.79M | 37.06M | 22.30M | 2.83M | 24.43K | 1.00M |
| Interest Income | 0.00 | 675.00K | 383.00K | 18.00K | -837.00K | 0.00 | 0.00 | 223.00K | 1.44M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 5.46M | 1.70M | 3.76M | 3.80M | 3.26M | 1.64M | 779.00K | 201.00K | 783.32K | 7.34M | 3.71M | 480.59K | 102.39K | 0.00 | 0.00 |
| Depreciation & Amortization | 331.00K | 465.00K | 659.00K | 849.00K | 1.46M | 2.13M | 2.82M | 1.98M | 708.98K | 475.32K | 171.59K | 787.20K | 7.95K | 0.00 | 0.00 |
| EBITDA | -8.91M | 5.33M | -14.43M | -6.01M | -7.19M | 610.00K | -48.16M | -11.62M | -14.30M | -8.74M | -19.40M | -18.30M | -1.80M | -24.43K | -995.89K |
| EBITDA Ratio | -14.12% | 8.27% | -18.11% | -6.82% | -5.98% | 0.46% | -28.86% | -6.55% | -14.53% | -16.62% | -93.09% | -452.19% | -177.14% | 0.00% | -12,481.39% |
| Operating Income | -7.40M | 4.86M | -15.09M | -6.86M | -7.57M | -1.52M | -50.97M | -13.60M | -16.82M | -11.62M | -19.57M | -19.09M | -1.81M | -24.43K | -995.89K |
| Operating Income Ratio | -14.78% | 7.54% | -18.94% | -7.78% | -7.41% | -1.14% | -30.55% | -7.67% | -15.17% | -17.33% | -93.91% | -471.64% | -177.92% | 0.00% | -12,481.39% |
| Total Other Income/Expenses | -5.48M | 564.00K | -3.76M | -3.80M | -3.64M | 5.50M | -779.00K | -201.00K | -783.32K | -7.34M | -3.35M | -836.91K | -6.45K | 0.00 | 0.00 |
| Income Before Tax | -12.87M | 3.17M | -18.84M | -10.66M | -10.83M | -3.16M | -51.75M | -13.80M | -17.60M | -18.95M | -22.92M | -19.93M | -1.82M | -24.43K | -995.89K |
| Income Before Tax Ratio | -25.73% | 4.91% | -23.65% | -12.09% | -10.60% | -2.38% | -31.02% | -7.78% | -15.88% | -28.26% | -109.99% | -492.32% | -178.55% | 0.00% | -12,481.39% |
| Income Tax Expense | 8.00K | -19.00K | 86.00K | 100.00K | 142.00K | 318.00K | 105.00K | 33.00K | 115.48K | 7.34M | 3.71M | 480.59K | 102.39K | 0.00 | 0.00 |
| Net Income | -12.88M | 3.19M | -18.93M | -10.76M | -10.97M | -3.48M | -51.86M | -13.83M | -17.72M | -26.29M | -26.63M | -20.41M | -1.92M | -24.43K | -995.89K |
| Net Income Ratio | -25.74% | 4.94% | -23.76% | -12.21% | -10.74% | -2.62% | -31.08% | -7.80% | -15.98% | -39.20% | -127.80% | -504.19% | -188.61% | 0.00% | -12,481.39% |
| EPS | -0.31 | 0.08 | -0.92 | -0.72 | -0.79 | -0.26 | -3.81 | -1.25 | -2.46 | -18.02 | -80.45 | -421.77 | -3.74K | -47.52 | -1.94K |
| EPS Diluted | -0.31 | 0.08 | -0.92 | -0.72 | -0.79 | -0.26 | -3.81 | -1.25 | -2.46 | -18.02 | -80.45 | -421.77 | -3.74K | -47.52 | -1.94K |
| Weighted Avg Shares Out | 41.17M | 41.17M | 20.48M | 15.02M | 13.88M | 13.44M | 13.62M | 11.07M | 7.19M | 1.46M | 331.03K | 48.38K | 514.00 | 514.00 | 514.00 |
| Weighted Avg Shares Out (Dil) | 41.17M | 41.17M | 20.48M | 15.02M | 13.88M | 13.44M | 13.62M | 11.07M | 7.19M | 1.46M | 331.03K | 48.38K | 514.00 | 514.00 | 514.00 |
MusclePharm Announces Colorado Distribution Partnership with New Age, Inc.
New Age, Inc. Represents Eighth Signed Distributor for MP Performance Energy and FitMiss Functional Energy Products
MusclePharm Closes Potential $7.3 Million Liability with IRS
CALABASAS, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- On April 6, 2016, the Internal Revenue Service (“IRS”) selected MusclePharm Corporation's (OTCMKTS: MSLP) 2014 Federal Income Tax Return for audit and, as a result, proposed certain adjustments with respect to the...
MusclePharm Names 11th Largest Accounting Firm, Moss Adams, as Independent Auditor
CALABASAS, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- MusclePharm Corporation (OTCMKTS: MSLP), a global provider of leading sports nutrition & lifestyle branded nutritional supplements, announced today that the Audit Committee of its Board of Directors has engaged Moss Adams LLP...
MusclePharm Closes More Pre-Orders Bringing Pre-Production Sales Orders to Approximately $600,000
CALABASAS, Calif., June 17, 2021 (GLOBE NEWSWIRE) -- MusclePharm Corporation (OTCMKTS: MSLP), a global provider of leading sports nutrition & lifestyle branded nutritional supplements, today reported that they have closed approximately $600,000 in pre-orders for MP Performance Energy, their new...
MusclePharm Closes $500,000 in Initial Orders for MP Performance Energy Line Through Collective Distributors
CALABASAS, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- MusclePharm Corporation (OTCMKTS: MSLP), a global provider of leading sports nutrition & lifestyle branded nutritional supplements, today reported that they have closed $500,000 in initial orders for MP Performance Energy, their new...
MusclePharm Appoints New Independent Board Member
CALABASAS, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- MusclePharm Corporation (OTCMKTS: MSLP), a global provider of leading sports nutrition & lifestyle branded nutritional supplements, today reported the appointment of Paul Karr as a new independent Board Member. With a history...
MusclePharm Corporation's (MSLP) CEO Ryan Drexler on Q1 2021 Results - Earnings Call Transcript
MusclePharm Corporation's (MSLP) CEO Ryan Drexler on Q1 2021 Results - Earnings Call Transcript
MusclePharm Delivers Profitable First Quarter 2021 Despite Industry Wide Supply Shortages
Operating expenses declined ~$0.8 million or 20% in First Quarter 2021
MusclePharm to Announce First Quarter 2021 Financial Results on Monday, May 24, 2021
CALABASAS, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- MusclePharm Corporation (OTCMKTS: MSLP), a global provider of leading sports nutrition and lifestyle branded nutritional supplements, announced today that the Company will report its financial results for the first quarter ended March...
MusclePharm Announces Multi-State Distribution Partnership with The Odom Corporation, NW Beverage & Craig Stein Beverage
CALABASAS, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- MusclePharm Corporation (OTCMKTS: MSLP), a global provider of leading sports nutrition and lifestyle branded nutritional supplements, today announced a multi-State distribution partnership to include Washington, Oregon, Idaho & Alaska with The Odom...
Source: https://incomestatements.info
Category: Stock Reports